97 related articles for article (PubMed ID: 7668154)
1. Neuroendocrine effects of interferon-alpha in the rat.
Saphier D
Adv Exp Med Biol; 1995; 373():209-18. PubMed ID: 7668154
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of neural and neuroendocrine activity by alpha-interferon: neuroendocrine, electrophysiological, and biochemical studies in the rat.
Saphier D; Roerig SC; Ito C; Vlasak WR; Farrar GE; Broyles JE; Welch JE
Brain Behav Immun; 1994 Mar; 8(1):37-56. PubMed ID: 8003770
[TBL] [Abstract][Full Text] [Related]
3. Alpha-interferon inhibits adrenocortical secretion via mu 1-opioid receptors in the rat.
Saphier D; Welch JE; Chuluyan HE
Eur J Pharmacol; 1993 May; 236(2):183-91. PubMed ID: 8391456
[TBL] [Abstract][Full Text] [Related]
4. Inhibition by the serotonin1A agonist, 8-hydroxy-2- (di-n-propylamino)tetralin, of antidromically identified paraventricular nucleus neurons in the rat.
Saphier D; Zhang K
Brain Res; 1993 Jun; 615(1):7-12. PubMed ID: 8364726
[TBL] [Abstract][Full Text] [Related]
5. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms mediating the effects of cytokines on neuroendocrine functions in the rat.
Rivier C; Rivest S
Ciba Found Symp; 1993; 172():204-20; discussion 220-5. PubMed ID: 8491087
[TBL] [Abstract][Full Text] [Related]
7. Chronic kappa opioid receptor antagonism produces supersensitivity to U-50,488H at the hypothalamo-pituitary-adrenocortical (HPA) axis level.
Alcaraz C; Milanés MV; Vargas ML
J Pharmacol Exp Ther; 1993 Sep; 266(3):1385-9. PubMed ID: 8396634
[TBL] [Abstract][Full Text] [Related]
8. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level.
Alcaraz C; Vargas ML; Fuente T; Milanés MV
J Pharmacol Exp Ther; 1993 Sep; 266(3):1602-6. PubMed ID: 8396640
[TBL] [Abstract][Full Text] [Related]
9. Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat.
Buckingham JC; Cooper TA
Neuroendocrinology; 1986; 42(5):421-6. PubMed ID: 3010154
[TBL] [Abstract][Full Text] [Related]
10. Role of nitric oxide in regulating the rat hypothalamic-pituitary-adrenal axis response to endotoxemia.
Rivier C
Ann N Y Acad Sci; 2003 May; 992():72-85. PubMed ID: 12794048
[TBL] [Abstract][Full Text] [Related]
11. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212
[TBL] [Abstract][Full Text] [Related]
12. Central administration of aminoprocalcitonin inhibits food intake and stimulates the hypothalamic-pituitary-adrenal axis in rats via the corticotrophin-releasing factor system.
Tavares E; Maldonado R; Garcia-Martinez A; Miñano FJ
J Neuroendocrinol; 2012 Jul; 24(7):1040-54. PubMed ID: 22372932
[TBL] [Abstract][Full Text] [Related]
13. Evidence of lasting dysregulation of neuroendocrine and HPA axis function following global cerebral ischemia in male rats and the effect of Antalarmin on plasma corticosterone level.
de la Tremblaye PB; Raymond J; Milot MR; Merali Z; Plamondon H
Horm Behav; 2014 Mar; 65(3):273-84. PubMed ID: 24444675
[TBL] [Abstract][Full Text] [Related]
14. Reduced response of the hypothalamo-pituitary-adrenal axis to alpha1-agonist stimulation during lactation.
Windle RJ; Brady MM; Kunanandam T; Da Costa AP; Wilson BC; Harbuz M; Lightman SL; Ingram CD
Endocrinology; 1997 Sep; 138(9):3741-8. PubMed ID: 9275060
[TBL] [Abstract][Full Text] [Related]
15. Hypothalamic-pituitary-adrenocortical responses to single vs. repeated endotoxin lipopolysaccharide administration in the rat.
Takemura T; Makino S; Takao T; Asaba K; Suemaru S; Hashimoto K
Brain Res; 1997 Sep; 767(2):181-91. PubMed ID: 9367246
[TBL] [Abstract][Full Text] [Related]
16. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
Larsen PJ; Tang-Christensen M; Jessop DS
Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
[TBL] [Abstract][Full Text] [Related]
17. Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression.
Felger JC; Alagbe O; Hu F; Mook D; Freeman AA; Sanchez MM; Kalin NH; Ratti E; Nemeroff CB; Miller AH
Biol Psychiatry; 2007 Dec; 62(11):1324-33. PubMed ID: 17678633
[TBL] [Abstract][Full Text] [Related]
18. Chronic stimulation of the hypothalamus-pituitary-adrenal axis in rats by interleukin 1beta: central and peripheral mechanisms.
van der Meer MJ; Sweep CG; Pesman GJ; Tilders FJ; Hermus AR
Cytokine; 1996 Dec; 8(12):910-9. PubMed ID: 9050749
[TBL] [Abstract][Full Text] [Related]
19. Centrally administered murine-leptin stimulates the hypothalamus-pituitary- adrenal axis through arginine-vasopressin.
Morimoto I; Yamamoto S; Kai K; Fujihira T; Morita E; Eto S
Neuroendocrinology; 2000 Jun; 71(6):366-74. PubMed ID: 10878498
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline.
Hadley AJ; Kumari M; Cover PO; Osborne J; Poyser R; Flack JD; Buckingham JC
Br J Pharmacol; 1996 Oct; 119(3):463-70. PubMed ID: 8894165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
